PharmOptima is a technology advanced company focused on expediting drug discovery through research, analysis and consulting for third party organizations. PharmOptima helps clients create data packages to maximize the value of their intellectual property through lead Selection and Optimization, Efficacy, PK/PD, Drug Metabolism and PK ADME.
Since 2003, PharmOptima has been providing clients with multidisciplinary input to discover and expedite solutions to drug discovery for our customers.
PharmOptima focuses on the mid to late phases of drug discovery between target identification and selection of lead compounds, helping clients select the best candidates to accelerate drug development and increase chances for clinical success. PharmOptima also provides consultation and laboratory support for target selection. PharmOptima's clients save time and money by identifying both the best drug candidates and identifying potential problems early.
PharmOptima offers both GLP and non-GLP bioanalytical services, DM and PK, PK/PD, proof of concept services and consulting.
The founding scientists at PharmOptima have an average more than 20 years of experience and a successful R&D track record in cardiovascular, CNS, oncology, dermatology and infectious diseases.
As part of our commitment to continually improve and update our company and its processes, PharmOptima has redesigned its website to provide current information about who we are and what we do. We hope you like our new look.
Like our website, PharmOptima has undergone a few changes as well. We continue to enhance our clinical processes, make investments in our laboratory equipment and are proud of our great project team. We provide extraordinary service while expediting the drug discovery process...which is what our customers have come to expect.
From our quality to our consistency, from our scientific integrity to our project team approach, all our efforts are geared toward providing our customers with exactly what they want.
(269) 329-4370
www.pharmoptima.com
